Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dwight L Evans

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
CNS Spectrums|March 11, 2003
Depression and HIV infection: impact on immune function and disease progressionDean G Cruess, John M Petitto, Jane Leserman, et al.
Current Psychiatry Reports|November 12, 2003
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus diseaseDean G Cruess, Steven D Douglas, John M Petitto, et al.
Biological Psychiatry|April 12, 2005
The role of stress-induced cortisol in the relationship between depression and decreased bone mineral densityPatricia M Furlan, Tom Ten Have, Mark Cary, et al.
The American Journal of Psychiatry|November 3, 2005
Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive womenDean G Cruess, Steven D Douglas, John M Petitto, et al.
AIDS and Behavior|October 12, 2004
Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigationTeri T Baldewicz, Jane Leserman, Susan G Silva, et al.
Biological Psychiatry|January 4, 2016
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune CellsJeffrey M Greeson, David R Gettes, Sergei Spitsin, et al.
Journal of Translational Medicine|May 28, 2016
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVJeffrey S Barrett, Sergei Spitsin, Ganesh Moorthy, et al.
Current HIV Research|May 28, 2014
Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitantJeffrey S Barrett, Gaurav Bajaj, Jennifer McGuire, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Corticosterone modulates auditory gating in mouseChristina R Maxwell, Richard S Ehrlichman, Yuling Liang, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
CNS Spectrums|March 11, 2003
Depression and HIV infection: impact on immune function and disease progressionDean G Cruess, John M Petitto, Jane Leserman, et al.
Current Psychiatry Reports|November 12, 2003
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus diseaseDean G Cruess, Steven D Douglas, John M Petitto, et al.
Biological Psychiatry|April 12, 2005
The role of stress-induced cortisol in the relationship between depression and decreased bone mineral densityPatricia M Furlan, Tom Ten Have, Mark Cary, et al.
The American Journal of Psychiatry|November 3, 2005
Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive womenDean G Cruess, Steven D Douglas, John M Petitto, et al.
AIDS and Behavior|October 12, 2004
Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigationTeri T Baldewicz, Jane Leserman, Susan G Silva, et al.
Biological Psychiatry|January 4, 2016
The Selective Serotonin Reuptake Inhibitor Citalopram Decreases Human Immunodeficiency Virus Receptor and Coreceptor Expression in Immune CellsJeffrey M Greeson, David R Gettes, Sergei Spitsin, et al.
Journal of Translational Medicine|May 28, 2016
Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVJeffrey S Barrett, Sergei Spitsin, Ganesh Moorthy, et al.
Current HIV Research|May 28, 2014
Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitantJeffrey S Barrett, Gaurav Bajaj, Jennifer McGuire, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Corticosterone modulates auditory gating in mouseChristina R Maxwell, Richard S Ehrlichman, Yuling Liang, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
Pageof 5